ArticleFrontiers in pharmacology2022

Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking.

Shakeel Ahmad Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.